3 news items
Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies
AEMD
3 Jun 24
S.A. Noonan Communications, LLC
Aethlon Medical Announces Pricing of $4.7 Million Public Offering
AEMD
15 May 24
:Susan NoonanS.A. Noonan Communications, LLC
Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma
AEMD
10 May 24
NoonanS.A. Noonan Communications, LLC
- Prev
- 1
- Next